Search Results for “ oncology” – Page 69 – media

EUSA bags EU approval for kidney cancer drug

The European Commission has licensed EUSA Pharma’s Fotivda for the management of adult patients with advanced kidney cancer across the European Union as well as Norway and Iceland.
- Source: open-medical
- 575
- August 30, 2017
cancer inhibitor kidney New Approvals
Merck sees promise in Macrophage Pharma

Merck Ventures has become the latest group to invest in Macrophage Pharma and take a position on the UK biotech’s board of directors.
- Source: pharmatimes
- 633
- August 25, 2017
Clinical Market Views Merck
US regulators wave through Pfizer’s leukaemia drug

Pfizer’s Besponsa has been approved by the US Food and Drug Administration (FDA). It's the first and only CD22-directed antibody-drug conjugate indicated to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).
- Source: pharmatimes
- 1,044
- August 21, 2017
ALL antibody Company Insight FDA New Approvals
Roche reports strong performance in the first half of 2017

Commenting on the Group’s results, Roche CEO Severin Schwan said: “In the first half of the year, both our Pharmaceuticals and Diagnostics Divisions showed strong performance, very much driven by new product launches. Particularly pleasing is the very successful launch of Ocrevus for the treatment of two forms of multiple sclerosis. Based on our half-year performance, we raised the outlook for the full-year to mid-single digit sales growth.”
- Source: www.roche.com
- 512
- August 4, 2017
Company Insight
10th International Conference on Clinical and Surgical Ophthalmology

Location: New South Wales, Australia Venue Address: DoubleTree by Hilton Beijing 168 Guang An Men Wai Avenue Xi Cheng District Beijing China Date: 07 Aug,2017 – 09 Aug,2017 Organizer: Sarika James Brief Conference Series LLC cordially invites you to participate at the 10th International Conference on Clinical and Surgical Ophthalmology to be held during August 07-09, 2017 at Beijing, China. The theme of the conference is “Exploring the novel research and trends in clinical and surgical ophthalmology” which focuses on the significance of vision and also explore the spectrum of latest technological developments in the field of Ophthalmology. Ophthalmology Conference 2017 maximizes the opportunity to interact with and learn from your peers from across the country and across the globe. Detailed Description: Conference Series LLC cordially invites you to participate at the 10th International Conference on Clinical and Surgical Ophthalmology to be held during August 07-09, 2017 at Beijing, China. ...
- Source: medical-events
- 624
- August 4, 2017
Clinical Exhibitions & Activities surgical
GSK delivers further progress in Q2 and sets out new priorities for the Group

GSK delivers further progress in Q2 and sets out new priorities for the Group
- Source: www.gsk.com/
- 378
- August 4, 2017
Company Insight
AZ, Merck link to develop and commercialise cancer drugs

AstraZeneca and Merck & Co have announced a global strategic oncology collaboration to co-develop and co-commercialise the former’s Lynparza and selumetinib for multiple cancer types.
- Source: pharmatimes
- 494
- July 31, 2017
cancer Lynparza Market Views Researches therapy
Samsung launches new mobile full-body CT scanner

Samsung Electronics’ healthcare unit Samsung NeuroLogica has launched a new mobile, portable full-body computed tomography (CT) scanner, BodyTom Elite.
- Source: Medicaldevice-network-com
- 553
- July 26, 2017
Company Insight CT scanner New Approvals
Medical Devices Market in Malysia

Malaysia represents one of the most vigorous and vibrant medical device markets in Southeast Asia, presenting opportunities for U.S. exporters of medical technology to expand their sales into rising economies. Increasing patient access to healthcare will remain in the focus of the Government of Malaysia for the next five years, to include upgrading facilities and equipment, and expanding delivery systems.
- Source: Ddu
- 636
- July 15, 2017
Malaysia Market Reports
A choice for Chang’an Pharmaceutical to win global orders

It is delighted that Chang'an Pharmaceutical became the 100th VIP member of Ddu. It is Ddu’s honor to invite Chang'an Pharmaceutical for the interview. Drugdu will continue to focus on the optimization of the online and offline services, committing to create more friendly, more humane medical trade ecosystem in the future.No matter it is the 1st member or the 1,000th one, Ddu will try the best. We are always with you.
- Source: drugdu
- 926
- June 20, 2017
Ddu News pharmaceutical

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.